Pierre Cougoul
Overview
Explore the profile of Pierre Cougoul including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
86
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stirnemann J, Serratrice J, Mann T, Louge P, Christophe C, Samii K, et al.
BMJ Open
. 2024 Nov;
14(11):e084825.
PMID: 39613437
Introduction: Sickle cell disease (SCD) is one of the most common genetic diseases in the world, annually affecting approximately 310 000 births and causing >100 000 deaths. Vaso-occlusive crisis (VOC)...
2.
Rivet V, Sibaud V, Dion J, Duteurtre S, Biteau M, Pages C, et al.
Rev Med Interne
. 2024 Nov;
PMID: 39580255
Immunological checkpoint inhibitors are now part of the oncological therapeutic arsenal in many solid cancers and malignant blood diseases, at the cost of immuno-mediated toxicities, of which dermatological disorders are...
3.
Schiro P, Barus R, Chouchana L, Sari R, Cougoul P, Montastruc F, et al.
Therapie
. 2024 Oct;
PMID: 39482118
No abstract available.
4.
Benyahia R, Syrykh C, Gaible C, Belliere J, Colombat M, Delas A, et al.
Lancet Haematol
. 2024 Oct;
11(11):e878.
PMID: 39482020
No abstract available.
5.
Guillemin C, Bellon N, Jachiet M, Barbarot S, Bourrat E, Chiaverini C, et al.
J Am Acad Dermatol
. 2024 Sep;
92(1):165-168.
PMID: 39343308
No abstract available.
6.
Walter O, Cougoul P, Zadro Y, Moulis G, Lafaurie M
Eur J Intern Med
. 2024 Jun;
128:143-144.
PMID: 38824077
No abstract available.
7.
Rivet V, Sibaud V, Dion J, Volosov T, Biteau M, Pastissier A, et al.
Front Oncol
. 2024 Mar;
14:1353896.
PMID: 38515568
Introduction: Immune checkpoint inhibitors (ICIs) are used in several advanced malignancies and may cause various immune-related adverse events (irAEs). Among them, hematological irAEs are less described. Acquired amegakaryocytic thrombocytopenia (AAT)...
8.
Ferreira De Matos C, Cougoul P, Zaharie O, Kermorgant M, Pavy-Le Traon A, Gales C, et al.
Eur J Neurol
. 2024 Jan;
31(4):e16183.
PMID: 38165013
Background And Purpose: White matter lesions (WMLs) are frequent in sickle cell disease (SCD), with a prevalence described to be as high as 53% by age 30. Cerebrovascular regulation and...
9.
Rieu J, Jamme T, Astudillo L, Mansour-Hendili L, Levade T, Cougoul P
EJHaem
. 2023 Nov;
4(4):1166-1167.
PMID: 38024623
No abstract available.
10.
Fischer M, Olbrich P, Hadjadj J, Aumann V, Bakhtiar S, Barlogis V, et al.
J Allergy Clin Immunol
. 2023 Nov;
153(1):275-286.e18.
PMID: 37935260
Background: Inborn errors of immunity (IEI) with dysregulated JAK/STAT signaling present with variable manifestations of immune dysregulation and infections. Hematopoietic stem cell transplantation (HSCT) is potentially curative, but initially reported...